Breast Cancer Clinical Trials in Nashville

Showing 321-340 of 352 trials

Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer

NCT01238952

The primary objective is to determine the maximum tolerated dose/recommended phase II dose of the combination regimen of NK012 and carboplatin in patients with advanced solid tumors.

Advanced Solid TumorsMetastatic Triple Negative Breast Cancer

Nippon Kayaku Co., Ltd.4 participantsStarted Jul 2010

Nashville, Tennessee, United States

COMPLETEDPHASE2< 1 mile

Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer

NCT00193037

The efficacy of single agent liposomal doxorubicin as compared to single agent docetaxel will be evaluated as first line treatment in metastatic breast cancer patients, with subsequent crossover to the opposite arm at disease progression or patient intolerance. We will explore this as well as any possible cross resistance between these two agents.

Breast Cancer

SCRI Development Innovations, LLC102 participantsStarted Feb 2001

Nashville, Tennessee, United States

COMPLETED< 1 mile

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

NCT00900406

RATIONALE: Collecting and storing samples of blood, urine, and tissue from patients undergoing a donor stem cell transplant to test in the laboratory may help the study of graft-versus-host disease in the future. PURPOSE: This research study is collecting and storing tissue and DNA samples from patients undergoing a donor stem cell transplant.

Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more

Vanderbilt-Ingram Cancer Center190 participantsStarted Jan 2007

Nashville, Tennessee, United States • Nashville, Tennessee, United States • Nashville, Tennessee, United States

Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer

Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Breast Cancer Trials in Other Cities

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast Cancer

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer

Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer

Nutrition Intervention in Treating Women With Breast Cancer

A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer

Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer

Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer

Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)

MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery

Other Conditions in Nashville